Avantor Investor Day Presentation Deck

1. RESEARCH & DEVELOPMENT Biopharma R&D landscape is rapidly expanding Innovation hubs R&D SOURCES BIOPHARMA PLATFORMS Small molecule Navantor™ Biotech Pharma companies mAbs Government partnerships Viral Vector Cell therapy Academic and industry partnerships Academia Gene therapy avantor mRNA Neuroscience Rare genetics Business Solutions THERAPEUTIC AREAS Bio Supply agreement through 2029 Ⓡ Vaccines Oncology Infectious diseases Gastro- enterology 23

View entire presentation